Materialise (NASDAQ:MTLS – Get Free Report) issued its earnings results on Thursday. The software maker reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03, Zacks reports. Materialise had a return on equity of 4.08% and a net margin of 3.77%.The firm had revenue of $76.72 million for the quarter, compared to the consensus estimate of $77.06 million.
Here are the key takeaways from Materialise’s conference call:
- Materialise transferred its RapidFit and Eyewear businesses to their management teams (retaining a minority stake in Eyewear), a strategic move intended to let Materialise focus capital and leadership on its core segments.
- Medical momentum continued with launches of custom-made PEEK cranio‑maxillofacial implants across Europe and OrthoView 3D Hip, broadening surgeon options and strengthening Materialise’s integrated MedTech ecosystem.
- Software traction accelerated—early access and pre-sales for CO‑AM Professional (seven customers onboarding) with full availability mid‑June, and a partnership to bundle Magics Print with HP’s MJF 1200 (commercial from early 2027) to expand market reach.
- Q1 financials showed resilience—revenue EUR 66.3m (stable y/y despite FX headwinds), improved gross margin (>57%), Adjusted EBIT EUR 2.5m, Adjusted EBITDA EUR 8m, and a stronger net cash position of EUR 72.8m with positive free cash flow.
- Manufacturing revenue declined 8% driven by soft prototyping and European automotive weakness (though sequentially improving and returning to positive EBITDA), while management reaffirmed full‑year guidance of EUR 273–283m revenue and EUR 10–12m adjusted EBIT.
Materialise Stock Performance
Shares of MTLS stock opened at $5.41 on Friday. The company has a market capitalization of $319.57 million, a P/E ratio of 27.05 and a beta of 1.28. The business’s 50 day moving average is $5.19 and its two-hundred day moving average is $5.56. The company has a current ratio of 2.43, a quick ratio of 2.27 and a debt-to-equity ratio of 0.19. Materialise has a 12-month low of $4.78 and a 12-month high of $6.80.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Materialise
Hedge Funds Weigh In On Materialise
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. grew its position in shares of Materialise by 116.8% in the fourth quarter. Pacer Advisors Inc. now owns 4,726 shares of the software maker’s stock valued at $26,000 after purchasing an additional 2,546 shares during the period. Federation des caisses Desjardins du Quebec increased its stake in shares of Materialise by 209.4% during the fourth quarter. Federation des caisses Desjardins du Quebec now owns 13,092 shares of the software maker’s stock worth $73,000 after purchasing an additional 8,861 shares in the last quarter. Quadrature Capital Ltd purchased a new stake in shares of Materialise during the fourth quarter worth about $56,000. Osaic Holdings Inc. increased its stake in shares of Materialise by 1,453.3% during the second quarter. Osaic Holdings Inc. now owns 11,650 shares of the software maker’s stock worth $66,000 after purchasing an additional 10,900 shares in the last quarter. Finally, NewEdge Advisors LLC raised its holdings in shares of Materialise by 19,063.2% during the second quarter. NewEdge Advisors LLC now owns 13,031 shares of the software maker’s stock valued at $74,000 after acquiring an additional 12,963 shares during the last quarter. 19.30% of the stock is owned by hedge funds and other institutional investors.
Materialise Company Profile
Materialise NV is a Belgium-based company specializing in 3D printing software and additive manufacturing services. Through its dual focus on software and printing, the company addresses a wide range of industries, including automotive, aerospace, consumer goods, and healthcare. Materialise’s offerings span from design and simulation tools to end-to-end production, delivering both standardized and highly customized parts across polymer and metal platforms.
On the software side, Materialise develops a suite of proprietary applications—such as Magics for data preparation, Mimics for medical image processing and patient-specific modeling, and Streamics for production workflow management.
Read More
Receive News & Ratings for Materialise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Materialise and related companies with MarketBeat.com's FREE daily email newsletter.
